
Sorafenat contains Sorafenib 200 mg, a targeted cancer therapy used for liver cancer, kidney cancer, and thyroid cancer. It works by blocking signals that promote tumor growth and spread.
| Generic Name | Sorafenib |
| Manufacturer | NATCO |
| Packing | 120 Tablets |
| Prescribed For | Liver cancer, kidney cancer, and thyroid cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.